Laura Sepplorenzino Net Worth & Insider Trades
Laura Sepplorenzino - EVP, Intellia Therapeutics, Inc
What is Laura Sepplorenzino's Net Worth?
The current estimated net worth of Intellia Therapeutics, Inc's EVP, Laura Sepplorenzino, is estimated to be about $19.03M . Laura Sepplorenzino owns about 17,629 units of Intellia Therapeutics, Inc common stock. In the last 4 years at Intellia Therapeutics, Inc, Laura Sepplorenzino has sold an estimated value of $18.92M worth.
What is Laura Sepplorenzino's Past Insider Trading?
Laura Sepplorenzino's largest purchase order was 97,000 units , worth over $1.36M on September 1, 2021. Laura Sepplorenzino's largest sale order was 97,000 units , worth over $15.02M on September 1, 2021. In total, Laura Sepplorenzino has made about 9 transactions over 4 years of their time at Intellia Therapeutics, Inc. Laura Sepplorenzino usually trades in March, with the busiest year in 2023 and 2021. The most recent transaction was a sale order of 4,838 units , worth over $182.98K on January 6, 2023.
Laura SeppLorenzino
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Laura Sepplorenzino's Salary in 2020?
As EVP of Intellia Therapeutics, Inc, Laura Sepplorenzino has a total base salary of $420,000 . Laura Sepplorenzino received compensation valued at about $1,690,526 in 2020 after becoming EVP. The vast majority of their compensation came in the form of a bonus of $184,800 , option awards of $1,081,148 , other compensation of $4,578 .
What is Laura Sepplorenzino's' Mailing Address?
- Mailing address is C/o Intellia Therapeutics, Inc. 40 Erie Street, Suite 130 Cambridge MA 02139 MA
Intellia Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| John M. Leonard, M.D. | 2020 | $580,000 | $319,000 | $2,722,890 | - | $13,786 | $3,635,676 |
| John M. Leonard, M.D. | 2019 | $559,200 | $307,560 | - | - | $37,026 | $903,786 |
| John M. Leonard, M.D. | 2018 | $550,000 | $302,500 | $7,818,005 | $1,011,713 | $26,112 | $9,708,330 |
| Glenn G. Goddard | 2020 | $407,000 | $146,520 | $1,001,063 | - | $8,928 | $1,563,511 |
| Glenn G. Goddard | 2019 | $383,000 | $153,200 | - | - | $5,644 | $541,844 |
| Glenn G. Goddard | 2018 | $67,718 | $51,652 | $1,896,825 | - | $218 | $2,016,413 |
| David Lebwohl, M.D. | 2020 | $298,378 | $228,000 | $1,549,720 | - | $2,690 | $2,078,788 |
| Andrew D. Schiermeier, Ph.D. | 2020 | $455,400 | $173,052 | $1,081,148 | - | $8,928 | $1,718,528 |
| Andrew D. Schiermeier, Ph.D. | 2019 | $440,000 | $167,200 | $611,897 | - | $8,778 | $1,227,875 |
| Andrew D. Schiermeier, Ph.D. | 2018 | $408,934 | $182,600 | $2,028,554 | $295,550 | $9,668 | $2,925,306 |
| Laura Sepp-Lorenzino, Ph.D. | 2020 | $420,000 | $184,800 | $1,081,148 | - | $4,578 | $1,690,526 |
| Laura Sepp-Lorenzino, Ph.D. | 2019 | $239,487 | $204,086 | $1,318,695 | - | $221 | $1,762,489 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1652130/000156459021021413/ntla-def14a_20210623.htm
What are Intellia Therapeutics, Inc's Past Insider Trades?
Intellia Therapeutics, Inc's most recent insider trade came on March 3, 2023 by James Basta who sold 1,088 units worth $47.74K . In the last 7 years, insiders at Intellia Therapeutics, Inc have sold an estimated value of $307.06M and bought an estimated value of $44M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are John Leonard, President and CEO, Francois Jean Formela, Director, and Jose Rivera, EVP .
Intellia Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||